Supernus Pharmaceuticals SUPN Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's change in other assets?
- Supernus Pharmaceuticals (SUPN) reported change in other assets of $12.43M in Q1 2026.
- How has Supernus Pharmaceuticals's change in other assets changed year-over-year?
- Supernus Pharmaceuticals's change in other assets increased by 268.6% year-over-year, from -$7.37M to $12.43M.
- What is the long-term trend for Supernus Pharmaceuticals's change in other assets?
- Over 2 years (2022 to 2025), Supernus Pharmaceuticals's change in other assets has grown at a 3.5% compound annual growth rate (CAGR), from -$12.3M to $13.18M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.